Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07409207 · ClinicalTrials.gov registry record · NA

Neurophysiology of Reward Signaling in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT07409207 is a NA study of Parkinson Disease that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 75 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07409207, a NA study of Parkinson Disease, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to learn more about the brain activity underlying Parkinson's disease risk taking and reward seeking behaviors. The investigators will utilize neural recordings from corticostriatal structures performed during deep brain stimulation surgery to measure neural activity underlying nonmotor symptoms of Parkinson's disease.

Conditions Studied

Interventions

  • OTHER Neurophysiology recordings
  • OTHER Neural stimulation

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2024-09-01
Est. Completion 2029-09-30
Phase NA

What the Registry Record Tells You About NCT07409207

The ClinicalTrials.gov registry entry for NCT07409207 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Neurophysiology recordings is the first listed.

NCT07409207 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT07409207 about?

NCT07409207 is a clinical study titled "Neurophysiology of Reward Signaling in Parkinson's Disease". The goal of this study is to learn more about the brain activity underlying Parkinson's disease risk taking and reward seeking behaviors. The investigators will utilize neural recordings from corticostriatal structures performed during deep brain stimulation surgery to measure neural activity underl...

What is the current status of trial NCT07409207?

This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2024-09-01. Estimated completion is 2029-09-30.

What conditions does trial NCT07409207 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT07409207?

The interventions under investigation include: Neurophysiology recordings (OTHER), Neural stimulation (OTHER).

Who is sponsoring clinical trial NCT07409207?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07409207 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.